Plus therapeutics announces poster presentation at the american association for cancer research (aacr) annual meeting

Austin, texas, april 08, 2022 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (the “company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced that the company will present a poster at the upcoming american association for cancer research (aacr) 2022 annual meeting, which is being held april 8-13, 2022, in new orleans, la., and virtually.
PSTV Ratings Summary
PSTV Quant Ranking